Clinical trial
Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting…
NCT00192803 · Rambam Health Care Campus, Other · Unknown status
Key facts
| NCT number | NCT00192803 |
|---|---|
| Title | Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Angiotensin Converting Enzyme 2 (ACE2): Diabetic Patients Treated With Antihypertensive Drugs |
| Official title | ACE/ACE2 Ratio in Diabetic Patients Treated With Antihypertensive Drugs |
| Lead sponsor | Rambam Health Care Campus, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | NIDDM |
| Intervention type | Drug |
| Interventions | candesartan |
| Enrollment | 20 |
| First posted | Sep 19, 2005 |
| Last update posted | Feb 23, 2006 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: